Nightstar Therapeutics plc — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2018)

-$36.9M

Total Assets (FY2018)

$180.0M

Total Equity (FY2018)

$165.6M

Cash Flows from Operating Activities (FY2018)

-$45.6M

Source: Nightstar Therapeutics plc 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.